Injection Rate and Erector Spinae Plane Block
Effect of Injection Rate on the Block Sensory Level in the Erector Spine Plane Block
1 other identifier
interventional
60
1 country
1
Brief Summary
To evaluate the effect of injection rate on the block sensory level in the ESP block.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable postoperative-pain
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 17, 2021
CompletedStudy Start
First participant enrolled
May 17, 2021
CompletedFirst Posted
Study publicly available on registry
May 20, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2021
CompletedJanuary 4, 2022
May 1, 2021
7 months
May 17, 2021
December 14, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Block sensory level
Number (average) of dermatomes with sensory block with pinprick and cold methods after the ESP block
12 hours
Secondary Outcomes (2)
Postoperative tramadol consumption
24 hours
Assesment of postoperative analgesia
24 hours
Study Arms (2)
Standard group
ACTIVE COMPARATORstandard injection rate will be applied
Long group
ACTIVE COMPARATORlong injection rate will be applied
Interventions
Ultrasound-guided ESP block with 20 mL %0.375 bupivacaine will be administered at a standard injection rate.
Ultrasound-guided ESP block with 20 mL %0.375 bupivacaine will be administered at a long injection rate.
Eligibility Criteria
You may qualify if:
- aged between eighteen and sixty-five
- ASA I-III
- undergo elective breast cancer surgery
You may not qualify if:
- under 18 years of age or over 65 years of age
- ASA IV and above
- declined to give written informed consent
- contraindications of peripheral blocks or local anesthetic infiltration
- history of allergy against local anesthetics
- chronic pain history
- history of hepatic, neuromuscular, cardiac and/or renal failure
- infection at the injection site
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Antalya Training and Research Hospital, Department of Anesthesiology and Reanimation
Antalya, 07100, Turkey (Türkiye)
Related Publications (1)
Barrios A, Camelo J, Gomez J, Forero M, Peng PWH, Visbal K, Cadavid A. Evaluation of Sensory Mapping of Erector Spinae Plane Block. Pain Physician. 2020 Jun;23(3):E289-E296.
PMID: 32517405BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Arzu Karaveli
Antalya TRH
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 17, 2021
First Posted
May 20, 2021
Study Start
May 17, 2021
Primary Completion
November 30, 2021
Study Completion
November 30, 2021
Last Updated
January 4, 2022
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share